Blood Preparation Market Size, Global Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Blood Preparation Market


The global Blood Preparation market size is projected to reach US$ 56.75 billion by 2026, from US$ 40.93 billion in 2020, at a CAGR of 5.6% during 2021-2026.Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market. According to the Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, blood transfusion was the most common procedure performed during hospitalizations for the period from 2006 to 2015 in U.S.

Some biopharmaceutical companies are financing resources for the development of new drugs. Organizations, such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), are taking initiatives for raising awareness levels via programs that aim to prevent thrombosis-associated complications in early stages. In addition, growing geriatric population base and rising healthcare expenditures are likely to boost the market further.

The introduction of novel technologies along with the increasing usage of plasma in pharmaceutical industry are further projected to contribute to the market growth over the forecast period. Various governments across the globe are focusing on increasing the number of blood donations by applying reimbursement policies, such as monetary incentives for donors. This factor is also expected to help augment the growth of the global market over the next few years.

Based on regional markets, North America is projected to be the largest market while APAC is expected to register the fastest growth during the forecast years. The growth of APAC region can be attributed to the presence of sophisticated healthcare infrastructure, especially in Japan and Australia. Moreover, favorable government initiatives and several untapped opportunities in the emerging markets of China and India will drive the regional market further.

Market Segmentation, Outlook & Viewpoint: Global Blood Preparation Market

Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

Whole Blood

  
Red Cells
  
Granulocytes
  
Plasma
  
Platelets

Blood Components

  
Whole Blood Components
  
Packed Red Cells
  
Leukocyte Reduced Red Blood Cells
  
Frozen Plasma
  
Platelet Concentrate
  
Cryoprecipitate

Blood Derivatives

Antithrombotic and Anticoagulants Type Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

Platelet Aggregation Inhibitors

  
Glycoprotein Inhibitors
  
COX Inhibitors
  
ADP Antagonists
  
Others

Fibrinolytics

  
Tissue Plasminogen Activator (tPA)
  
Streptokinase
  
Urokinase

Anticoagulants

  
Heparins
  
Unfractionated Heparin
  
Low Molecular Weight Heparin (LMWH)
  
Ultra-low Molecular Weight Heparin
  
Vitamin K Antagonists
  
Direct Thrombin Inhibitors
  
Direct Factor Xa Inhibitors

Antithrombotic and Anticoagulants Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Thrombocytosis
  
Pulmonary Embolism
  
Renal Impairment
  
Angina Blood Vessel Complications
  
Others

Key Players, Recent Developments & Regional Insights: Global Blood Preparation Market

Based on product, the blood preparation market is segmented into whole blood, derivatives, and components. Whole blood product segment held the largest market share in 2018. Increasing demand for whole blood for major surgeries and transfusions along with its advantages, such as easy availability, low cost, and maintenance, is the major factor contributing to the segments high share.

On the other hand, blood derivatives is likely to be the fastest-growing segment over the forecast years. Presence of government initiatives for the development of plasma-derived proteins, such as immunoglobulins, coagulation factor products, human fibrin foam, dried human plasma, and human thrombin, are expected to drive market growth.
Blood derivatives, such as intravenous immunoglobulin and hyperimmune, are used to boost immunity in cases of life-threatening infections, such as Ebola. Increasing prevalence of such diseases, introduction of advanced technologies to separate the components, and launch of blood-derived medicines are the factors anticipated to boost the segment growth.

Antithrombotic and Anticoagulants Type Insights

The antithrombotic and anticoagulants market is categorized on the basis of type into platelet aggregation inhibitors, fibrinolytics, and anticoagulants. Among these, anticoagulants led the type segment in 2018 and is expected to register a lucrative CAGR from 2019 to 2026. This growth is attributed to the introduction of new products with higher efficacy and the potential commercialization of new products currently in the pipeline.
Biopharmaceutical companies are upgrading their products by launching novel and more efficient anticoagulant drugs in the market. Re-launch of some key drug products, such as Urokinase in North America, is expected to fuel its growth in the coming years. Anticoagulant drugs include heparins, vitamin K antagonists, direct thrombin inhibitors, and direct factor Xa inhibitors.

Antithrombotic and Anticoagulants Application Insights

Based on the application, the market has been segmented into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and others. Among these, antithrombotic products are widely used in thrombocytosis. Higher platelet count leads to coagulation of blood in the circulatory system, which ultimately causes life-threatening heart conditions. Thrombocytosis is classified as primary and secondary. Primary thrombocytosis is uncommon affecting around 24 individuals per million globally. It is prevalent in middle-aged people and in women below 40 years. Secondary thrombocytosis is more common due to the conditions, such as hyposplenism, splenectomy, asplenia, hemorrhage, osteosarcoma, and rheumatoid arthritis.

Angina blood vessel complications are expected to grow at the fastest CAGR during the forecast period owing to rising R&D for the development of anticoagulants for cardiac problems and increasing prevalence of Cardiovascular Disorders (CVDs). Angina pectoris is characterized by severe pain in the chest and discomfort owing to insufficient oxygen supply to the heart. Although the main treatment for angina is nitroglycerine, use of anticoagulants is significant owing to the frequency of complications in the former. Furthermore, rise in lifestyle-associated diseases, popularity of oral anticoagulants, growing patient awareness, increased healthcare expenditure, and favorable government policies are the factors driving the segment.

Regional Insights

North America led the overall market in terms of revenue in 2018 owing to high incidence of CVDs, leukemia, and hematological and neurological diseases in the region. Higher patient awareness and healthcare expenditure levels along with the presence of sophisticated healthcare infrastructure will boost the regions growth further. Asia Pacific is expected to witness the fastest growth on account of improving healthcare infrastructure, presence of untapped opportunities, economic development, and rising initiatives by private and public organizations.

Blood Preparation Market Share Insights

Key companies in the market are AstraZeneca PLC; Sanofi S.A.; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International, Inc.; Pfizer, Inc.; Portola Pharmaceuticals, Inc.; and GlaxoSmithKline PLC. Most of the companies have adopted strategies, such as new product launches, mergers and acquisition, and collaborations, to increase their market share. For instance, in June 2017, Portola Pharmaceuticals, Inc. received FDA approval for the commercial launch of Bevyxxa, a novel oral anticoagulant drug.

Key Insights Covered: Global Blood Preparation Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Blood Preparation industry.
2. Global major manufacturers" operating situation (sales, revenue, growth rate and gross margin) of Blood Preparation industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Blood Preparation industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Blood Preparation industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Blood Preparation industry.

Research Methodology: Global Blood Preparation Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other